Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

A mailed fecal immunochemical test (FIT) outreach followed by patient navigation for those with a positive test increased colorectal cancer (CRC) screening participation at 6 months compared with ...

Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

An at-home FIT test (Fecal Immunochemical Test) is one of the easiest ways to screen for colon cancer. This short explainer video shows who needs a FIT test, how it works, and how to ask your doctor ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Completing one ...

FIT outperformed cfDNA in detecting advanced precancerous colorectal lesions, showing higher sensitivity and specificity. Blood-based tests offer easier implementation and potentially higher adherence ...

Please provide your email address to receive an email when new articles are posted on . In this Healio video, Rasmi Nair, MBBS, MPH, PhD, reports findings from a recent study, which showed 10% of ...

Please provide your email address to receive an email when new articles are posted on . Patients who received mailed outreach had a higher rate of screening completion at 6 months vs. those who ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

The analysis included 1103 people (aged 52 to 85 years) who died from colorectal adenocarcinoma between 2011 and 2017, and 9608 controls. HealthDay News — Screening with fecal immunochemical tests ...

While screening for colorectal cancer (CRC) with a blood-based test would result in better outcomes than no screening at all, it would likely result in worse outcomes than currently available tests -- ...